Article History
Received: 19 April 2018
Accepted: 28 April 2018
First Online: 9 May 2018
Compliance with ethical standards
:
: Matteo Lambertini acknowledges the support from the European Society for Medical Oncology (ESMO) for a Translational Research Fellowship at Institut Jules Bordet, Brussels, Belgium, and he served as a consultant for Teva outside the submitted work. The other authors declare no conflict of interest in relation to this article.
: Not applicable.